midazolam has been researched along with Heart Septal Defects, Ventricular in 5 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate the clinical effects of dexmedetomidine combined with midazolam in postoperative intensive care following pediatric cardiac surgery." | 1.42 | Dexmedetomidine in combination with midazolam after pediatric cardiac surgery. ( Hasegawa, T; Maruo, A; Matsuhisa, H; Matsushima, S; Noda, R; Oshima, Y; Tanaka, A, 2015) |
| "A perimembranous ventricular septal defect (7 mm) and an ostium secundum atrial septal defect (8." | 1.37 | [Simultaneous transcatheter treatment of perimembranous ventricular septal defect and secundum atrial septal defect in an adult: first application in Turkey]. ( Arı, H; Arı, S; Bozat, T; Koca, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, T | 1 |
| Oshima, Y | 1 |
| Maruo, A | 1 |
| Matsuhisa, H | 1 |
| Tanaka, A | 1 |
| Noda, R | 1 |
| Matsushima, S | 1 |
| Arı, H | 1 |
| Arı, S | 1 |
| Koca, V | 1 |
| Bozat, T | 1 |
| Laird, TH | 1 |
| Stayer, SA | 2 |
| Rivenes, SM | 1 |
| Lewin, MB | 1 |
| McKenzie, ED | 1 |
| Fraser, CD | 1 |
| Andropoulos, DB | 2 |
| Ikemba, CM | 1 |
| Su, JT | 1 |
| Miller-Hance, WC | 1 |
| Eidem, BW | 1 |
| Bezold, LI | 1 |
| Hall, SR | 1 |
| Havemann, LM | 1 |
| Riley, DP | 1 |
| McBride, LJ | 1 |
2 trials available for midazolam and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease.
Topics: Adolescent; Anesthetics, Inhalation; Anesthetics, Intravenous; Child; Child, Preschool; Double-Blind | 2002 |
Myocardial performance index with sevoflurane-pancuronium versus fentanyl-midazolam-pancuronium in infants with a functional single ventricle.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Coronary Angiography; Dose-Response Relationship, | 2004 |
3 other studies available for midazolam and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Dexmedetomidine in combination with midazolam after pediatric cardiac surgery.
Topics: Cardiac Surgical Procedures; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2015 |
[Simultaneous transcatheter treatment of perimembranous ventricular septal defect and secundum atrial septal defect in an adult: first application in Turkey].
Topics: Anesthetics, Intravenous; Clopidogrel; Echocardiography, Transesophageal; Female; Fluoroscopy; Heart | 2011 |
Ketamine, midazolam and vecuronium infusion. Anaesthesia for Down's syndrome and congenital heart disease.
Topics: Adult; Anesthesia, Intravenous; Cataract Extraction; Down Syndrome; Female; Heart Septal Defects, Ve | 1991 |